http://www.enlivex.com
Enlivex Therapeutics Ltd. Company Intro
Enlivex Therapeutics Ltd., a clinical stage immunotherapy company, engages in developing allogeneic drugs for immune system rebalancing. Its product candidate is Allocetra, an immunotherapy candidate for the prevention of complications post bone marrow transplantations; treatment of patients that do not respond to steroid treatment upon occurrence of graft vs host disease post bone marrow transplantations; and prevention of cytokine storms, organ damage, and multiple organ failure in sepsis patients. The company also intends to develop its cell-based therapy to be combined with treatments of solid tumors via immune checkpoint rebalancing to enhance the efficacy of various anti-cancer therapies, including chimeric antigen receptor T-Cell therapy and therapies targeting T-Cell receptor therapy. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.
Industry
Healthcare
Enlivex Therapeutics Ltd. Headquaters
14 Einstein Street
Nes Ziona,7403618
Israel
Enlivex Therapeutics Ltd. Share price
14 Sep 2022 09:08 GMT
$5.16
-0.11 (-2.09 %)
Enlivex Therapeutics Ltd. Market cap
$92.936 M
WMC RANKING
2023
Enlivex Therapeutics Ltd. # 477
BiotechnologyLatest Enlivex Therapeutics Ltd. News
WMC Market Score
WMC Market to Revenue Score
Enlivex Therapeutics Ltd. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Enlivex Therapeutics Ltd. | USD | $0 | $11,691 | $-14,230 | $929M | 477 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Enlivex Therapeutics Ltd. Social Followers vs Top 4 Industry Competitors
Enlivex Therapeutics Ltd. Post vs Top 4 Industry Competitors
Enlivex Therapeutics Ltd. Digital Footprint By Size vs Top 4 Industry Competitors
Enlivex Therapeutics Ltd. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Enlivex Therapeutics Ltd. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Enlivex Therapeutics Ltd. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
